Unknown

Dataset Information

0

Circulating and tissue biomarkers in early-stage non-small cell lung cancer.


ABSTRACT: OBJECTIVE:We sought to characterise circulating and tissue tumour biomarkers of patients who developed early-stage non-small cell lung cancer (NSCLC) during long-term follow-up of a chemoprevention trial (NCT00321893). MATERIALS AND METHODS:Blood and sputum samples were collected from 202 high-risk asymptomatic individuals with CT-detected stable lung nodules. Real-time PCR was performed on plasma to quantify free circulating DNA. Baseline serum was investigated with a previously validated test based on 13 circulating miRNAs (miR-Test). Promoter methylation status of p16, RASSF1a and RAR?2 and telomerase activity were assessed in sputum samples. DNA was extracted from each tumour developed during follow-up and subjected to a mutation survey using the LungCarta panel on the Sequenom MassARRAY platform. RESULTS:During follow-up (9 years) six individuals underwent surgery for stage I NSCLC with a median time of disease onset of 20.5 months. MiR-Test scores were positive (range: 0.14-7.24) in four out of six baseline pre-disease onset sera. No association was identified between free circulating DNA or sputum biomarkers and disease onset. All tumours harboured at least one somatic mutation in well-known cancer genes, including KRAS (n = 4), BRAF (n = 1), and TP53 (n = 3). CONCLUSION:Circulating miRNA tests may represent valuable tools to detect clinically-silent tumours. Early-stage lung adenocarcinomas harbour recurrent genetic events similar to those described in advanced-stage NSCLCs.

SUBMITTER: Fumagalli C 

PROVIDER: S-EPMC5295844 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature

altmetric image

Publications


<h4>Objective</h4>We sought to characterise circulating and tissue tumour biomarkers of patients who developed early-stage non-small cell lung cancer (NSCLC) during long-term follow-up of a chemoprevention trial (NCT00321893).<h4>Materials and methods</h4>Blood and sputum samples were collected from 202 high-risk asymptomatic individuals with CT-detected stable lung nodules. Real-time PCR was performed on plasma to quantify free circulating DNA. Baseline serum was investigated with a previously  ...[more]

Similar Datasets

| S-EPMC6407000 | biostudies-literature
| S-EPMC4254270 | biostudies-other
| S-EPMC4428831 | biostudies-literature
| S-EPMC4939988 | biostudies-literature
| S-EPMC8099172 | biostudies-literature
| S-EPMC8299278 | biostudies-literature
| S-EPMC4995492 | biostudies-literature
| S-EPMC7553089 | biostudies-literature
| S-ECPF-GEOD-7898 | biostudies-other
| S-EPMC3387223 | biostudies-literature